SFRS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.810000E-01
Normal-vs-Stage2
4.350000E-01
Normal-vs-Stage3
3.131400E-01
Normal-vs-Stage4
4.739400E-01
Stage1-vs-Stage2
6.384400E-01
Stage1-vs-Stage3
8.395000E-01
Stage1-vs-Stage4
3.111600E-01
Stage2-vs-Stage3
4.678600E-01
Stage2-vs-Stage4
5.727600E-01
Stage3-vs-Stage4
4.904000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.303600E-01
Normal-vs-AfricanAmerican
2.854000E-01
Normal-vs-Asian
1.063990E-01
Caucasian-vs-AfricanAmerican
9.722600E-01
Caucasian-vs-Asian
5.834200E-01
AfricanAmerican-vs-Asian
7.566800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.016800E-01
Normal-vs-Female
4.630200E-01
Male-vs-Female
2.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.349600E-01
Normal-vs-Age(41-60Yrs)
4.826600E-01
Normal-vs-Age(61-80Yrs)
6.421600E-02
Normal-vs-Age(81-100Yrs)
4.371000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.063200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.100400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.798600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.246350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.702200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.465570E-01
Normal-vs-Daily Drinker
8.027700E-02
Normal-vs-Weekly Drinker
1.771800E-01
Normal-vs-Occasional Drinker
4.735200E-01
Normal-vs-Social Drinker
1.244840E-01
Non Drinker-vs-Daily Drinker
6.382800E-01
Non Drinker-vs-Weekly Drinker
9.689600E-01
Non Drinker-vs-Occasional Drinker
6.997600E-01
Non Drinker-vs-Social Drinker
9.305800E-01
Daily Drinker-vs-Weekly Drinker
6.484800E-01
Daily Drinker-vs-Occasional Drinker
3.750800E-01
Daily Drinker-vs-Social Drinker
7.238800E-01
Weekly Drinker-vs-Occasional Drinker
7.715800E-01
Weekly Drinker-vs-Social Drinker
9.044800E-01
Occasional Drinker-vs-Social Drinker
6.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.747600E-01
Normal-vs-Grade 2
5.708400E-01
Normal-vs-Grade 3
5.734000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.936500E-02
Grade 1-vs-Grade 3
1.127610E-01
Grade 1-vs-Grade 4
3.747600E-01
Grade 2-vs-Grade 3
9.517000E-01
Grade 2-vs-Grade 4
5.708400E-01
Grade 3-vs-Grade 4
5.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.414500E-02
Normal-vs-NonDiabetic
4.300200E-01
Diabetic-vs-NonDiabetic
3.332000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.376200E-01
Normal-vs-NoPancreatitis
4.077600E-01
Pancreatitis-vs-NoPancreatitis
6.692600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.061040E-01
Normal-vs-N1
4.194600E-01
N0-vs-N1
4.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.755200E-01
Normal-vs-TP53-NonMutant
9.037600E-02
TP53-Mutant-vs-TP53-NonMutant
5.909900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
